Clearmind Medicine (CMND) Total Non-Current Liabilities (2021 - 2026)
Clearmind Medicine's Total Non-Current Liabilities came in at $44,347 for fiscal Q2 2026 (quarter ended Apr 30, 2026), down 92.1% from $560,723 a year earlier and down 96.1% from the prior quarter.
Powered by 
Analysis
Clearmind Medicine (CMND) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2024 (ended Oct 31, 2024), Clearmind Medicine's Total Non-Current Liabilities was $16,416, down 99.7% from FY2023.
- Total Non-Current Liabilities carries a three-year compound annual growth rate of 10.8% (FY2021 to FY2024).
- Going back by fiscal year, Total Non-Current Liabilities was $4.97 million in FY2023 (+185.3%), $1.74 million in FY2022 and $12,052 in FY2021.
- The fiscal Q2 2026 figure represents the lowest quarterly Total Non-Current Liabilities since fiscal Q1 2025.
- Year-over-year, Total Non-Current Liabilities increased in 1 of the last five quarters, with an average decline of 69.3%.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q4 2023 (growth of 194.6%), and the weakest in fiscal Q4 2024 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Clearmind Medicine | 9,526.05 | -39.89 Mn | - | 101,920.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 101,920.00 |
| Apr 30, 2026 | 44,347.00 |
| Jan 31, 2026 | 1.15 Mn |
| Jul 31, 2025 | 725,178.00 |
| Apr 30, 2025 | 560,723.00 |
| Jan 31, 2025 | 6,903.00 |
| Oct 31, 2024 | 16,416.00 |
| Jul 31, 2024 | 25,578.00 |
| Apr 30, 2024 | 468,165.00 |
| Jan 31, 2024 | 30,507.00 |
| Oct 31, 2023 | 4.97 Mn |
| Jul 31, 2023 | 964,510.00 |
| Apr 30, 2023 | 120,378.00 |
| Jan 31, 2023 | 127,653.58 |
| Oct 31, 2022 | 537,062.47 |
| Oct 31, 2021 | 6,690.37 |
API Access
Clearmind Medicine Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();